Pharmacogenetic (CYP2D6) and gene expression profiles (HOXB13/IL17BR and molecular grade index) for prediction of adjuvant endocrine therapy benefit in the ABCSG 8 trial.
暂无分享，去创建一个
R. Greil | R. Weinshilboum | Xiao-Jun Ma | M. Erlander | M. Gnant | M. Goetz | J. Ingle | H. Samonigg | R. Jakesz | V. Suman | M. Ames | C. Marth | J. Ingle | Stephanie L. Safgren | M. Kuffel | M. Filpits